JonesTrading Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 7 08:31 ET · Ratings

Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsMar 3 08:31 ET · Ratings

Aldeyra Therapeutics Analyst Ratings

BenzingaMar 3 08:03 ET · Ratings

H.C. Wainwright Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 3 07:34 ET · Ratings

Optimistic Buy Rating for Aldeyra Therapeutics Amid Promising FDA Review and Potential AbbVie Collaboration

TipRanksMar 3 06:37 ET · Ratings

Institutional Investors in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) See US$94m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

Simply Wall StMar 1 07:01 ET